|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product revenue, net | |||||
| Collaboration revenue | |||||
| Revenue - related party | |||||
| Other revenue | |||||
| Related Party | |||||
| Total other revenue | |||||
| Net revenue | |||||
| Operating expenses | |||||
| Cost of goods - (excluding amortization of acquired intangible assets) | |||||
| Amortization of acquired intangible assets | |||||
| Research and development | |||||
| Research and development - licenses acquired | |||||
| Selling, general and administrative | |||||
| Loss recovery | |||||
| Asset impairment | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Interest income | |||||
| Interest expense and financing fee | |||||
| Change in fair value of warrant liabilities | |||||
| Loss on common stock warrant liabilities | |||||
| Gain from deconsolidation of subsidiary | |||||
| Other income | |||||
| Total other income (expense) | |||||
| Loss before income tax expense | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Attributable to non-controlling interests | |||||
| Net income (loss) attributable to Fortress | |||||
| Preferred A dividends declared and paid and/or cumulated, and Fortress' share of subsidiary deemed dividends | |||||
| Net loss attributable to common stockholders | |||||
| Net loss per common share attributable to common stockholders - basic | |||||
| Net loss per common share attributable to common stockholders - diluted | |||||
| Weighted average common shares outstanding - basic | |||||
| Weighted average common shares outstanding - diluted | |||||
Loading...